Resumen de: MX2025008037A
Systems and methods for monitoring glucose variability are described. Data indicative of glucose levels of the subject is received. A first glucose metric is determined in a first time period. A second glucose metric is determined in a second time period. A difference between the second and first glucose metrics are determined. The difference is compared to a threshold. A first indicator is displayed if the difference does not exceed the threshold and a second indicator is displayed if the difference exceeds the threshold. In some embodiments, the indicator is one of a balanced state or a steady state and the second indicator is one of an unbalanced state, an unsteady state, a not steady state, or a spiky state.
Nº publicación: CN120418886A 01/08/2025
Solicitante:
ABBOTT DIABETES CARE INC
\u96C5\u57F9\u7CD6\u5C3F\u75C5\u62A4\u7406\u516C\u53F8
Resumen de: CN120418886A
An analyte monitoring system and method for an on-body sensor control device may have the ability to sense two or more analytes of a patient, the sensor control device comprising a processor and a memory, there are instructions for determining various machine states and outputs based on time-dependent sensor data for each analyte. The status and output may include: alarm conditions for one or more analytes; consulting a message; a correction of the analyte state estimate; indication of failure of the sensor control device, failure of the insulin delivery device, drug dose calculation; or analyzing the report. Examples of systems and methods for dual analytes including glucose and ketones are described. Data may be transmitted from the sensor control device to the reader device for output to a user.